Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check50 days agoChange DetectedThe company name has been updated from 'Madison Vaccines, Inc' to 'Madison Vaccines Incorporated'.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check65 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.1%
Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.